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Experimental Study on Fibrinolytic Phenomena 
of Injured Cerebral Tissues 
一－WithSpecial Reference to the Changes in 
Fibrinolytic Substances in Glia Tissues-
HARUOKI T ADOKORO 
Second Department of Surgery, School of Medicine, Toho University 
(Director : Prof. Dr. SABURo AwAzu) 
Experimental chronic head injuries were made in the cerebrum of mature dogs by 
incision, and the amount of reactively proliferated fibrinolytic substance in Glia tissues was 
determined. Further, the changes in the fibrolytic function following administration of 
various remedies against head injuries were investigated so that the intracellular distribution 
sites as well as status of distribution of the fibrinolytic substance could be studied by the 
in trace lluar fractionation. 
1. Aggregation pattern of Glia cells was noted in coincidence with the injured area 
through photomicroscopic inspection of the cerebral tissues of the injured dogs. 
2. The plasminogen activator and the proactivator occurring in the cerebral tissues of 
healthy dogs were found respectively to have been most concentrated into the lysosome 
fraction and the microsome fraction, while the trypsin inhibitor was found to be distri・ 
buted within the granulocytes which indicated the maximum rate of control with the 
lysosome fraction. 
3. Both plasminogen activator and proactivator were found to have been markedly in・ 
creased, while trypsin inhibitor slightly increased both in the Glia tissues, but their 
locations and status of distribution within the granulocytes were found to be the di・ 
ferent as in the h巴althydogs. 
Key words: Fibrinolytic phenomena of injured cerebral tissues, Fibrinolytic substances in Glia tisues 
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損傷脳組織の線維素溶解現象に関する実験的研究 259 
-L Both plasminogen activator and proactivator were found to have been increased, while 
trypsin inhibitor slightly increased both in the cerebral tissues of the controls, but their 
locations and status of distribution within the granulocytes were found to be the same 
as in the healthy dogs. 
5. In the Glia tissues of dogs to which prednisolone and trans-AMCHA were administer-
ed, the control of plasminogen activator and drop in the proactivator were noted, 
whereas the effect for increasing trypsin inhibitor did not show any consistent trend. 
Also in the controls, the effect to control the plasminogen activator was noted, but the 
effect for reducing proactivator was poor and the effect to increase the trypsin inhibitor 
was not found out. 
Both the effects for the maximum control of plasminogen activator and the maxi-
mum reduction of proactivator in the Glia tissues were noted at the locations of gran-
ulocytes in the Glia tissues of dogs to which the above-mentioned remedies were not 
administered. 
6. In the Glia tissues of dogs to which cytochrome C and citicoline were administered, 
the effect for controlling plasminogen activator could be noted, but the effects to reduce 
proactivator or to increase trypsin inhibitor did not show any consistent trend. In 
contrast, the effects for reducing plasminogen activator and proactivator were found 
to have been poor, and these can not be therefore regarded as antifibrolytic agents 

















Proactiva tor （以下 Proact.）の存在を認め， Todd8>9>
も動脈系l乙SK.で活性化される物質を認めて報告し
ている．一方， 線溶物質に対する諸種の抗線溶物質の






分画に Act.を，そのよ清に Inhibitor（以下 Inh.)
を認め， Sasakiet aJ13＞は，人鼻粘膜Mitochondria
分繭中に Act.を認め， Aliand Lack14＞は，家兎腎
の Lysosome分画に多量の， Microsome分画に少







































































検体 l.Ogに 0.25MSucrose液 （pH7.0) lOmlを加














ombin （持田製民）は，生食水を加えて 60U/mll:'. 
し， Trypsin（持国製薬）は生食水を加えて 64U/ml
とした.SK. It. Varidase (Lederle Co.）の HX削
U/ml 11 .ft水前日立を使用した．線溶物質抽出液どして
0.25M Sucrose if~ (pH 7.0）を使用したJI).
5. Fibrin Plate作成法

























3) Trypsin inhibitor 
各分画溶液 0.lmlに64U/mlTrypsin O.lmlを混










































30.4 T %, Microsome 22.0 T %. Nuclei 8.5 T %, 




Inhは， TissueHomogenate 45.6 T %，細胞分商に
よる！：：，Lysosome分画で 67.6T%と抑制率は最
も高〈，次いで Mitochondria51.0T0o, Microsome 






































｜活性値 ｜ 細胞分画 l活性値｜ 細 胞分画 ｜抑制率
I 36.0土 2.12 i Microsome ¥ 49. O土2.83 I Lysosome I 67. 6土3.02 
I 3o. 4土2.73 : Lysoso耐 I4s. s二3.47 I Mitochondria ' 51. 0土2.0 
l 22.0土1.41 l Nuclei ', 19. 6: 1.乃 lMicrosome 34. 4土2.70 
: 8. 5二O.68 , Supernatant 1. O土O.93 Supernatant ' 21. 7土1.6 
: 4. 2土O.38 ; Mitocho耐 1a 34. 2 2. 10 Nuclei 16. 3±0. 91 
一 一ーーー ーー－












actは， 図3の如（ , Tissue Homog芭nateで43.l
ρb，細胞分函では Mitochondria119.0T %.次いで
Lysosome 97.6 T o 0, Supernatant 42.0 T ~io , Nuclei 
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活性値 ｜ 細胞分画 活性 値 細胞分 画 1
119. O士3.00 ] Lysosome ¥147. 0 ＿←7. 68 ! Mitochondria ! sz.6二5.14 
! 97. 6 4. 66 ! Microsome I 43. 0土3.82 ' Lysosome 77. 1二4.26 
I 42. o土2.83 I Mitochondria J128. 5土4.46 ! Supernatant 52. 5工3.08
119.一1I Nuclei I 18.山
16.旧お i Supernatant I 31. 1土1.81 ! Microsome 竺三主主
Tissue Homoger附 143.l士3.93 ! Tissue Homogenate [ 74. 1士6.45 [ Tissue Homogenate 50. 1-L3.子
Trypsin inhibitor 
抑制l率


















T o~. 細胞分画によ る と， Mitochondria 82.6 T %. 
Lysosome 7.1 T %. Supernatant 52.5 T 0 o, Nuclei 
27.4T %で健康犬と比べていずれも高値を示したが







なう と Pig.actは， Nuclei12.5T%, Mitochond
ria 
46.2 T 0 ;, Lysosome 72.0 T %, Microsome
 32.0T 







































































細胞 分 画 ｜抑制率
Lysosome I 75.3:4.弧
Mitochondria I 57. 3:'3. 62 
Microsome I 38.7:':?. 08 
Supernatant ¥ 24. 4土I.的
Nuclei 1 20. 4土I.凶
一ー 一ーー一一一一一ー 一 ーー ーー －－
Tissue Homogenate . 49. 0土2.70 
ムー ーーーーー戸
Proactivator 
細胞 分 画 活 性値
M icrosome 86. 4 . z. 47
Lysosome ! 68.8 ' 6. 10 I 
Mitochondria i 59. 0: 3. 12 I 
Nuclei I 24. 6' 2. 09 i 
Supernatant / 16. 0令0.74




46. 2 _; 3. 45 I 
32. Oc 2. 46 I 
12. 5 1. 02 i 























Microsome 38.7 T %, Supernatant 24.4 T %, Nu-
clei 20.4T % と健康犬より増強しており Lysosome
分画の増強が最大であった．対照側でも線溶物質の変
動が認められたが， Pig.actの最大局部位は Lysoso’












































I 9o. 6土6.50 I Lysosome 1 68. 0 3. 46 
I ss. s土3.75 I Mitochondria 1 so.1 3. 82 
185.… 
27.4土1.21 Nuclei ' 32. 0 2. 4 0
f 14. 0土o.go I三竺：nat制 27. 6 ! l.＿~ 3 
I s3. o土2.01 I Tissue Homogen山 j52. 8 2. 86 
Proactivator 
画｜活性値 I
Mit刀chondria i 60. 9土3.37I 
Lysosome : 43. 5土o.92 I 
Microsome 29. 0士2.oo I 
Nuclei 19. 7士1.06 ! 
Supernatant , 10. 9土o.1s I 













た.Try. lnhは， TissueHomogenate 52.8T%で，
非投与例と変らず細胞分画によると， Mitochondria








効果が認められたが， Nuclei 19.7T0 •. Microsome 
29.0T0oと抑制lが認められなかった 活性値が最も減
少し，最大抑制効果を認めた分函は Mitochondriaで
あった.Proact は， TissueHomogenate, Mitoch‘ 
ondria, Lysosome分画で減少し， Nuclei,Microso・











































Proactivator 「 Trypsininhibitor 
活 性値 細胞分画 f 抑制率
一 一 一ー一一一一一一一一一一一一ー－
49. 6 . 1.07 Microsome 1 76. 5土3.61 
69. 7士3.08 Mitochondria 1 71.0土4.20 
79. 7 4. 11 1 Lysosome l 60. 6τ3. 75 
i 26. 0 2. 06 ! Nuclei i 26.4士2.06
I 11. 7’0. 41 Supernatant I 16. 1土1.07 
一 一 ↓一一一ー一一－
46. 5. 2. 37 Tissue Homogenate 48. 7: 1.14 









• 60. 4±5. 27 I 
I 48. 0二2.74 I 
18. 1・1.55 : 
16. 0= 1.02 I 











画では， Nuclei14.8T%, Mitochondria 48.0T00 
Lysosome 60.4T0;,, Microsome 18.1T%. Superna-
tant 16.0T%と全ての分画で著明な抑制傾向を認め，
最大抑制効果は Mitochondria分画に認めた Proact 
は， TissueHomogenateで減少，細胞分画を行なう
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Tissue Homogenate 39. 4土3.00
Plasminogen a伽 a伽 j Pro訓 V山 I Trypsin 凶 bito 
｜活性値！ 細 胞 分画 ｜活性値｜ 細胞 分繭 ｜相l制率
I 58. 0土2.22 Lyso喧ome 109. 0土8.81 i Lysosorr i 73. 7土3伺
52.3士3.81 Microsome , 62. O土4.27 i Mitochondria ! 64. O－ニ3.05
36. 3 c 1.61 Mitochondria ! 77. 1士5.30 I Microsome I 55. 7土2.19 
23.6土1.08 I N叫 lei ! 34. 5:;,2. 01I Nuclei [ 42. l土1.88 
19. 0±1. 52 Supernatant i 17.0工O.75 I Supernatant i 33.0= 1.40 




らず， Mitochondria64.0T0o, Supernatant 33.0T"o 
と減弱したが， Nuclei42.1T%. Microsome 55.7T•占
と増強を示し， Supernatantで最も減弱， Microsome
分画で最も増強した．その結果， 細胞頼粒内 Pig.act 

















Tissue Homogenate 48.7T~o. Nuclei 26.4T0 ， で非
投与例にくらべて変化なく， Mitochondria71.0T%, 
Lysosome 60.6T0,, Supernatant 16.lT'o t減弱し，
Microsome分画では 76.5T0o ヒ費量も泡強 Supern・
atantで最も減弱した したがって， Pig.actは
Lysosome分画を最大局在部位とする， Proa ctは
Microsome分画， Try.Inhは， 最大抑制2容を Mic-
rosome分画に認める非投与例とは異なった最大局布
部位および細胞頼約内分布状態を示した． （表5)
3) Cytochrome C 
図7に示す如く，CytochromeC投与グ リア組織
の Pig.act l土， TissueHomogenate 39.4 T %，細
胞分画によると Mitochondria52.3 T 0・o, Lysosome 
58.0T %, Supernatant 19.0T %と非投与例より活
性値は減少し，僅かな Pig.act抑制効果が認めら
れ， 最大抑制効果は Mitochondria分画に認めた
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Homogenate 25.1T%, Mitochondria 38.3T%. Ly-
sosome 52.8T0;,, Microsome 26.2T0o, Supernatant 







Tissue Homogenate 55.4T%, Lysosome分画 78.0
T%と非投与例と比較して変化を認めず， Mitochon-
dria 59.1T%. Supernatant 29.0T%と減弱するが，
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P!asmin en訓 va伽 I Pro訓
一竺胞分画 ｜活性値｜ 細 胞 分画 l活性値｜ 細胞分画 l叩竺主
M巾 ch叩 dria i 94.1x5. 01 ] Ly so喝Oil
Lysosome I 84. 7土4.29 I Microsome I 60. 8一4.06 I Mitochondria 5θ.1士2.10 
Microsome I 39. 0土2.57 I Nuclei I 31. 0土1.21 I Microsome 45. 0土2.00
Nuclei 117. 5土0.19 I Mitochondria jl似舵7.061 Nuιlei 44. 7±3. 91 
Supernatant [ 13. 3二0.83 I Supernatant [ 18. 4士1.41 I Supernatant 1 29. 0斗 95








照側脳の Plg.actは， TissueHomogenate 21.7T%. 
細胞分画では Nuclei13.1T0>, Mitochondria 34.6T 
%. Lysosome 46.7T0;,, Microsome 20.0To,;, Supe・ 
rnatant 6.7T%で非投与例に比較して明らかな抑制
を認め， 最大抑制効果は Lysosome分薗に認めた．




Try. Inhは， TissueHomogenate 52.0T0 o, Nuclei 






































活性 値 ｜ 細胞分画 ！抑制竺
55.9工2.40 ¥ Mitochondria ! 68. 0土4.95 
81. 7土4.07 I Lysosome I 6.3士5.24 
¥ 54. 9 -3.19 j Micro町 n巴 ＼40.3土3日
I 25. 5土1.01 I Supernatant （ぉ6二3.01 
1 11. 0 • O. 44 ; Nuclei I 23. 9土1泌








52. 8 I 2.05 , 
















3) Cytochrome C 
Cytochrome C投与対照仮lj脳の Pig.actは， Ti-
ssue Homogenate 24.1T%, Lysosome分画59.0T%
と非投与例より減少するが，Nuclei分画 17.1T%,
Mitochondria分画 44.0T0・o,Microsome分画30.IT






Tissue Homogenate 47.1T%, Nuclei分画 26.3T%
ど非投与例とほぼ同じで， Lysosome分画では62.lT
%と最も減弱し， Mitochondria分画 70AT%.Mic-
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I Proactiva伽 i Trypsin凶 b伽
｜活性値｜ 細胞分函 l活性 値！ 細胞 分画 ｜抑制宇
一
146. 7土3.01 I Mier ！臼0二3.14 I Mitocho 
34.6土2.臼 lLysosorr I 76.1士4.25 ! Lysosome i臼.L-5. 21 
I 20.0土I.31 I Mitochondria I 49. 0士2.64 I Microsome I 46. 0 4. 00 
! 13.1土1.22 I Nuclei i 22. O土I.71 I Supernatant I 39. 6士2.52
i 6. 7土O.40 i Su附則ant I 8. 8土O.25 ! Nuclei 」竺土1竺

















Pig. actは， Tissue Homogenate 30.1T%，細胞分
画では，Nuclei19.4T%, Mitochondria 40.6T0o 





me分函の Proactが最も増加した Try. Inh t土，
Tissue Homogenate 54.5T ~o・細胞分画を行うと，
Nuclei 36.1T00, Mitochondria 72.4T0o, Microsome 
47.4T"o, Supernatant 42.0T0；， で非投与例より増強







圃園田 Tr~v~i11 inhibitor 
’！＇＇Yr, 
l~i( I 




































































67 . .J :t:3. 00 I Lysosome 
93.3二 7.94 ・. Mitochondria 
1 32. 0・・1. 11 I Microsome 
I 56.1土3.24 I Supernatant 
I 15. 8 ・ 110 I Nuclei 
52. 7 -2. 01 Tissue Homogenate 
画分Jl't! 細
! Praactiva tor 
活性値 ｜ 細胞分
59. 0 .o:3. 65 : Microsome 
44. 0 = 2.97 1 Lysosome 
30. 1土l.63 , Nuclei 
17. 1土1.08 1 Mitochondria 
12. 2 ' 0.81 i Supernatant 


















減少している. Try. lnhは， TissueHomogenate 
61.9T%.細胞分画では， Nuclei27.7T%, Mitochon-











細胞分画 i活性値｜ 細胞分蘭 ｜活性値 1 細胞 分爾 ｜抑旬 率
Lysosome I 62. 4土4.31 J Microsome I 71.O・: 4. 71 j Lysosome I 76. 6二5.随
Mitochondria i 40. 6士1.02 I Mitochondria I 62. 0土3.14 I Mitochondria i 67.1士4.90
Microsome I 32.1二 2.30 I Lysosome ! 77.5二5.01 I Supernatant i 47.0土3.23
Nuclei ! 19. 4土1.11 I Nuclei I 29. 8 1. 31 I Microsome I 35. 0士1.90 
Supernatant [ 13.日 65! Supernatant [ 20. 6±:0. 981 N山 lei ! 27. 7±1. 04 





Plasm in lζ変化させて Fibrinolysisを示す場合L
破壊された臓器の Lysokinaseが血中に入り，血中
の Proactが Pig.act lζ変化しそれによって Plas-
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